Promus PREMIER™ H7493952820400Recalls & reported problems
Boston Scientific Corporation · Everolimus-Eluting Platinum Chromium Coronary Stent System · Class 3 · Implant
All models of Promus PREMIER (56)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 08714729844815), received between May 3, 2017 and Apr 17, 2019 — classified as 1 injury, 3 malfunctions.
The most frequently reported specific device problem is “Break” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Break2
- Adverse Event Without Identified Device or Use Problem1
- Bent1
Patient problems
- No Consequences Or Impact To Patient3
- Diaphoresis1
- Discomfort1
- Paralysis1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
MalfunctionApr 17, 2019Break; Break
IT WAS REPORTED THAT SHAFT BREAK OCCURRED. THE TARGET LESION WAS LOCATED IN A CORONARY VESSEL. AFTER DEPLOYING A 4.00X20MM PROMUS PREMIER DRUG-ELUTING STENT, THE PHYSICIAN ATTEMPTED TO REMOVE THE DELIVERY SYSTEM; HOWEVER, THE SHAFT BROKE APPROXIMATELY 100CM FROM THE HUB. THE DISTAL END OF THE DELIVERY SHAFT WAS STILL INSIDE THE GUIDE CATHETER AND THE REST OF THE DEVICE WAS OUTSIDE THE PATIENT'S BODY. THE PHYSICIAN WAS THEN ABLE TO REMOVE THE GUIDE CATHETER FROM THE PATIENT'S BODY AND RETRIEVED THE BROKEN PIECE. THE PROCEDURE WAS COMPLETED WITH NO COMPLICATIONS WERE REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8524703 ↗InjuryJul 12, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
SAME CASE AS MDR ID #2134265-2018-06026. IT WAS REPORTED THAT PATIENT DISCOMFORT AND COMPLICATIONS OCCURRED. VASCULAR ACCESS WAS OBTAINED VIA THE RADIAL ARTERY. A PROMUS PREMIER¿ STENT WAS IMPLANTED THE OBTUSE MARGIN. AFTER THE PROCEDURE, UPON TRANSPORTATION BACK TO THE PATIENT'S ROOM, THE PATIENT BECAME DIAPHORETIC AND WAS BROUGHT BACK TO THE CATHETERIZATION LAB. THE PREVIOUSLY IMPLANTED STENT WAS WIDELY PATENT, HOWEVER, THERE WAS A FOCAL LESION IN THE RIGHT CORONARY ARTERY (RCA) THAT HAD BEEN UNDETECTED. A PROMUS PREMIER¿ STENT WAS THEN PLACED IN THE RCA. AFTER THE SECOND STENT WAS IMPLANTED, THE PATIENT'S ARM WAS "FROZEN" AND SEVERELY UNCOMFORTABLE. THE PATIENT'S CURRENT STATUS IS OKAY.
Patient problems: Diaphoresis; Discomfort; Paralysis
MAUDE report 7682085 ↗MalfunctionJun 6, 2018Break; Break
IT WAS REPORTED THAT SHAFT BREAK OCCURRED. A 4.00X20MM PROMUS PREMIER¿ STENT WAS ADVANCED FOR TREATMENT AND WAS SUCCESSFULLY DEPLOYED. HOWEVER, WHEN THE STENT DELIVERY SYSTEM WAS REMOVED POST-STENT DEPLOYMENT, IT WAS NOTED THAT THE SHAFT WAS BROKEN. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT'S STATUS WAS FINE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7574828 ↗MalfunctionMay 3, 2017Bent; Bent
IT WAS REPORTED THAT STENT DAMAGE OCCURRED. THE TARGET LESION WAS LOCATED IN A CORONARY ARTERY. A 4.00X20MM PROMUS PREMIER¿ DRUG-ELUTING STENT WAS ADVANCED BUT FAILED TO CROSS THE LESION. THE DEVICE WAS REMOVED; HOWEVER, IT WAS NOTED THAT A STENT STRUT WAS BENT. THE PROCEDURE WAS COMPLETED WITH ANOTHER 4.00X20MM PROMUS PREMIER¿ DRUG-ELUTING STENT. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT'S STATUS WAS FINE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6540052 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page